» Articles » PMID: 33503876

Comprehensive Review on the Clinical Relevance of Long Non-Coding RNAs in Cutaneous Melanoma

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2021 Jan 28
PMID 33503876
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Cutaneous melanoma is considered a rare tumor, although it is one of the most common cancers in young adults and its incidence has risen in the last decades. Targeted therapy, with BRAF and MEK inhibitors, and immunotherapy revolutionized the treatment of metastatic melanoma but there is still a considerable percentage of patients with primary or acquired resistance to these therapies. Recently, oncology researchers directed their attention at the role of long non-coding RNAs (lncRNAs) in different types of cancers, including melanoma. lncRNAs are RNA transcripts, initially considered "junk sequences", that have been proven to have a crucial role in the fine regulation of physiological and pathological processes of different tissues. Furthermore, they are more expressed in tumors than protein-coding genes, constituting perfect candidates either as biomarkers (diagnostic, prognostic, predictive) or as therapeutic targets. In this work, we reviewed all the literature available for lncRNA in melanoma, elucidating all the potential roles in this tumor.

Citing Articles

Lnc-PKNOX1-1 inhibits tumor progression in cutaneous malignant melanoma by regulating NF-κB/IL-8 axis.

Hong A, Cao M, Li D, Wang Y, Zhang G, Fang F Carcinogenesis. 2023; 44(12):871-883.

PMID: 37843471 PMC: 10818096. DOI: 10.1093/carcin/bgad073.


BRAF Mutations in Melanoma: Biological Aspects, Therapeutic Implications, and Circulating Biomarkers.

Castellani G, Buccarelli M, Arasi M, Rossi S, Pisanu M, Bellenghi M Cancers (Basel). 2023; 15(16).

PMID: 37627054 PMC: 10452867. DOI: 10.3390/cancers15164026.


Long non-coding RNA CCHE1 modulates LDHA-mediated glycolysis and confers chemoresistance to melanoma cells.

Ding Z, Yang J, Wu B, Wu Y, Guo F Cancer Metab. 2023; 11(1):10.

PMID: 37480145 PMC: 10360318. DOI: 10.1186/s40170-023-00309-z.


Pathogenic roles of long noncoding RNAs in melanoma: Implications in diagnosis and therapies.

Xiao Y, Xia Y, Wang Y, Xue C Genes Dis. 2023; 10(1):113-125.

PMID: 37013035 PMC: 10066279. DOI: 10.1016/j.gendis.2021.08.007.


A novel risk model based on cuproptosis-related lncRNAs predicted prognosis and indicated immune microenvironment landscape of patients with cutaneous melanoma.

Zhou Y, Shu Q, Fu Z, Wang C, Gu J, Li J Front Genet. 2022; 13:959456.

PMID: 35938036 PMC: 9354044. DOI: 10.3389/fgene.2022.959456.


References
1.
Li F, Li X, Qiao L, Liu W, Xu C, Wang X . MALAT1 regulates miR-34a expression in melanoma cells. Cell Death Dis. 2019; 10(6):389. PMC: 6525244. DOI: 10.1038/s41419-019-1620-3. View

2.
Yang Y, Xu W, Zheng Z, Cao Z . LINC00459 sponging miR-218 to elevate DKK3 inhibits proliferation and invasion in melanoma. Sci Rep. 2019; 9(1):19139. PMC: 6914790. DOI: 10.1038/s41598-019-55701-x. View

3.
Chen X, Dong H, Liu S, Yu L, Yan D, Yao X . Long noncoding RNA MHENCR promotes melanoma progression via regulating miR-425/489-mediated PI3K-Akt pathway. Am J Transl Res. 2017; 9(1):90-102. PMC: 5250706. View

4.
Pan B, Lin X, Zhang L, Hong W, Zhang Y . Long noncoding RNA X-inactive specific transcript promotes malignant melanoma progression and oxaliplatin resistance. Melanoma Res. 2019; 29(3):254-262. DOI: 10.1097/CMR.0000000000000560. View

5.
Yap K, Li S, Munoz-Cabello A, Raguz S, Zeng L, Mujtaba S . Molecular interplay of the noncoding RNA ANRIL and methylated histone H3 lysine 27 by polycomb CBX7 in transcriptional silencing of INK4a. Mol Cell. 2010; 38(5):662-74. PMC: 2886305. DOI: 10.1016/j.molcel.2010.03.021. View